Combination of prostacyclin and estrogen or progestin for the prevention and treatment of atherosclerotic vascular diseases, including pre-eclampsia, and for the treatment of hypertension, and hormone replacement therapy

摘要

Cardiovascular disease, including preeclampsia in pregnant women and hypertension in both women and men, are prevented or treated by administering thereto prostacyclin or a prostacyclin analog in combination with one or both of an estrogen and a progestin, which combination is also useful for HRT in peri- and post-menopausal women.